Answers are grounded in this paper and cite their sources.
Objective To ascertain the clinical significance and biological function of the circular RNA circMTOR in lung adenocarcinoma (LUAD). Methods The expression level of circMTOR was analyzed in clinical tissue specimens, and its correlation with clinicopathological characteristics was evaluated. An overexpression cell model was established to assess the effects of circMTOR on cell proliferation, migration, and invasion via CCK-8, Wound Healing Assay, transwell invasion, and colony formation assays. Furthermore, bioinformatics prediction combined with rescue experiments was employed to validate its downstream effector protein. Results The expression of circMTOR in LUAD tissues was significantly lower than that in paracancerous tissues and was negatively correlated with T stage and tumor differentiation grade ( P < 0.05). Functional assays demonstrated that circMTOR overexpression significantly suppressed the proliferative, invasive, and migratory capacities of lung cancer cells. Mechanistically, the RNA-binding protein FUS was identified as a key downstream target of circMTOR; reintroduction of FUS partially rescued the phenotypic inhibition mediated by circMTOR. Conclusion circMTOR functions as a tumor suppressor in LUAD potentially by regulating FUS, suggesting that it may serve as a potential diagnostic biomarker and therapeutic target for lung adenocarcinoma.
No takes yet. Share an insight, caveat, or question.
Lu et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: